Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M G Murray

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Schizophrenia Research|December 20, 2000
IQ scores of treatment-resistant schizophrenia patients before and after the onset of the illnessB B Sheitman, M G Murray, J A Snyder, et al.
Journal of Virology|October 24, 2000
Hepatitis C virus internal ribosome entry site (IRES) stem loop IIId contains a phylogenetically conserved GGG triplet essential for translation and IRES foldingR Jubin, N E Vantuno, J S Kieft, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 1, 1993
A multicenter study of the light visor for seasonal affective disorder: no difference in efficacy found between two different intensitiesN E Rosenthal, D E Moul, C J Hellekson, et al.
The American Journal of Psychiatry|April 1, 1993
Side effects of light therapy in seasonal affective disorderA J Levitt, R T Joffe, D E Moul, et al.
Psychiatry Research|January 1, 1993
Light visor treatment for seasonal affective disorder: a multicenter studyR T Joffe, D E Moul, R W Lam, et al.
Virology|November 15, 1996
Enhancement of hepatitis C virus NS3 proteinase activity by association with NS4A-specific synthetic peptides: identification of sequence and critical residues of NS4A for the cofactor activityN J Butkiewicz, M Wendel, R Zhang, et al.
Science (New York, N.Y.)|November 4, 1983
Phaseolin gene from bean is expressed after transfer to sunflower via tumor-inducing plasmid vectorsN Murai, J D Kemp, D W Sutton, et al.
Journal of Medicinal Chemistry|October 5, 2001
Piperazine-based CCR5 antagonists as HIV-1 inhibitors. II. Discovery of 1-[(2,4-dimethyl-3-pyridinyl)carbonyl]-4- methyl-4-[3(S)-methyl-4-[1(S)-[4-(trifluoromethyl)phenyl]ethyl]-1-piperazinyl]- piperidine N1-oxide (Sch-350634), an orally bioavailable, potent CCR5 antagonistJ R Tagat, R W Steensma, S W McCombie, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Schizophrenia Research|December 20, 2000
IQ scores of treatment-resistant schizophrenia patients before and after the onset of the illnessB B Sheitman, M G Murray, J A Snyder, et al.
Journal of Virology|October 24, 2000
Hepatitis C virus internal ribosome entry site (IRES) stem loop IIId contains a phylogenetically conserved GGG triplet essential for translation and IRES foldingR Jubin, N E Vantuno, J S Kieft, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 1, 1993
A multicenter study of the light visor for seasonal affective disorder: no difference in efficacy found between two different intensitiesN E Rosenthal, D E Moul, C J Hellekson, et al.
The American Journal of Psychiatry|April 1, 1993
Side effects of light therapy in seasonal affective disorderA J Levitt, R T Joffe, D E Moul, et al.
Psychiatry Research|January 1, 1993
Light visor treatment for seasonal affective disorder: a multicenter studyR T Joffe, D E Moul, R W Lam, et al.
Virology|November 15, 1996
Enhancement of hepatitis C virus NS3 proteinase activity by association with NS4A-specific synthetic peptides: identification of sequence and critical residues of NS4A for the cofactor activityN J Butkiewicz, M Wendel, R Zhang, et al.
Science (New York, N.Y.)|November 4, 1983
Phaseolin gene from bean is expressed after transfer to sunflower via tumor-inducing plasmid vectorsN Murai, J D Kemp, D W Sutton, et al.
Journal of Medicinal Chemistry|October 5, 2001
Piperazine-based CCR5 antagonists as HIV-1 inhibitors. II. Discovery of 1-[(2,4-dimethyl-3-pyridinyl)carbonyl]-4- methyl-4-[3(S)-methyl-4-[1(S)-[4-(trifluoromethyl)phenyl]ethyl]-1-piperazinyl]- piperidine N1-oxide (Sch-350634), an orally bioavailable, potent CCR5 antagonistJ R Tagat, R W Steensma, S W McCombie, et al.
Pageof 5